DataMetrex Signs LOI to Acquire Arbutus Health and Wellness Inc.
Datametrex AI (DTMXF) has signed a non-binding Letter of Intent to acquire Arbutus Health and Wellness Inc., a Vancouver-based multidisciplinary medical clinic, for $1.1 million. The acquisition will be completed through the issuance of common shares at $0.10 per share.
Arbutus Health provides walk-in services, family medicine, skin laser treatments, and specialty healthcare services in a single location. The transaction requires customary closing conditions, definitive agreements, and regulatory approvals.
In a separate announcement, Richard Yoon has resigned from the Board of Directors effective March 28, 2025, with the company initiating a search for his replacement.
Datametrex AI (DTMXF) ha firmato una Lettera di Intenti non vincolante per acquisire Arbutus Health and Wellness Inc., una clinica medica multidisciplinare con sede a Vancouver, per 1,1 milioni di dollari. L'acquisizione sar脿 completata attraverso l'emissione di azioni ordinarie a 0,10 dollari per azione.
Arbutus Health offre servizi di pronto intervento, medicina di famiglia, trattamenti laser per la pelle e servizi sanitari specializzati in un'unica sede. La transazione richiede le consuete condizioni di chiusura, accordi definitivi e approvazioni normative.
In un annuncio separato, Richard Yoon si 猫 dimesso dal Consiglio di Amministrazione con effetto dal 28 marzo 2025, con l'azienda che avvia una ricerca per il suo sostituto.
Datametrex AI (DTMXF) ha firmado una Carta de Intenci贸n no vinculante para adquirir Arbutus Health and Wellness Inc., una cl铆nica m茅dica multidisciplinaria con sede en Vancouver, por 1,1 millones de d贸lares. La adquisici贸n se completar谩 mediante la emisi贸n de acciones ordinarias a 0,10 d贸lares por acci贸n.
Arbutus Health ofrece servicios de atenci贸n m茅dica, medicina familiar, tratamientos l谩ser para la piel y servicios de salud especializados en una sola ubicaci贸n. La transacci贸n requiere las condiciones de cierre habituales, acuerdos definitivos y aprobaciones regulatorias.
En un anuncio separado, Richard Yoon ha renunciado a la Junta Directiva con efecto a partir del 28 de marzo de 2025, y la empresa ha iniciado la b煤squeda de su reemplazo.
Datametrex AI (DTMXF)鞚� 110毵� 雼煬鞐� 氚挫繝氩勳棎 氤胳偓毳� 霊� 雼ろ暀鞝� 鞚橂 韥措Μ雼夓澑 Arbutus Health and Wellness Inc.毳� 鞚胳垬頃橁赴 鞙勴暅 牍勱惮靻� 鞚橅枼靹滊ゼ 觳搓舶頄堨姷雼堧嫟. 鞚胳垬電� 欤茧嫻 0.10雼煬鞚� 氤错喌欤� 氚滍枆鞚� 韱淀暣 鞕勲霅� 鞓堨爼鞛呺媹雼�.
Arbutus Health電� 雼澕 鞙勳箻鞐愳劀 鞚戧笁 靹滊箘鞀�, 臧�鞝� 鞚橅暀, 頂茧秬 霠堨澊鞝� 旃橂 氚� 鞝勲 鞚橂 靹滊箘鞀るゼ 鞝滉车頃╇媹雼�. 鞚� 瓯半灅電� 甏�搿�鞝侅澑 毵堦皭 臁瓣贝, 斓滌 瓿勳暯 氚� 攴滌牅 鞀轨澑鞚� 鞖旉惮頃╇媹雼�.
氤勲弰鞚� 氚滍憸鞐愳劀 Richard Yoon鞚� 2025雲� 3鞗� 28鞚茧秬搿� 鞚挫偓須岇棎靹� 靷瀯頄堨溂氅�, 須岇偓電� 攴胳潣 頉勳瀯鞛愲ゼ 彀娟赴 鞁滌瀾頄堨姷雼堧嫟.
Datametrex AI (DTMXF) a sign茅 une lettre d'intention non contraignante pour acqu茅rir Arbutus Health and Wellness Inc., une clinique m茅dicale multidisciplinaire bas茅e 脿 Vancouver, pour 1,1 million de dollars. L'acquisition sera r茅alis茅e par l'茅mission d'actions ordinaires 脿 0,10 dollar par action.
Arbutus Health propose des services d'urgence, de m茅decine familiale, des traitements au laser pour la peau et des services de sant茅 sp茅cialis茅s en un seul endroit. La transaction n茅cessite des conditions de cl么ture habituelles, des accords d茅finitifs et des approbations r茅glementaires.
Dans une annonce s茅par茅e, Richard Yoon a d茅missionn茅 de son poste au conseil d'administration avec effet au 28 mars 2025, et la soci茅t茅 a lanc茅 une recherche pour le remplacer.
Datametrex AI (DTMXF) hat ein unverbindliches Absichtsschreiben zur 脺bernahme von Arbutus Health and Wellness Inc., einer multidisziplin盲ren medizinischen Klinik mit Sitz in Vancouver, f眉r 1,1 Millionen Dollar unterzeichnet. Die 脺bernahme wird durch die Ausgabe von Stammaktien zu 0,10 Dollar pro Aktie abgeschlossen.
Arbutus Health bietet Dienstleistungen f眉r Notf盲lle, Familienmedizin, Hautlaserbehandlungen und spezialisierte Gesundheitsdienste an einem einzigen Standort an. Die Transaktion erfordert die 眉blichen Abschlussbedingungen, endg眉ltige Vereinbarungen und regulatorische Genehmigungen.
In einer separaten Ank眉ndigung hat Richard Yoon mit Wirkung zum 28. M盲rz 2025 von seinem Posten im Vorstand zur眉ckgetreten, und das Unternehmen hat die Suche nach seinem Nachfolger eingeleitet.
- Strategic expansion into healthcare sector through $1.1M acquisition
- Diversification of revenue streams through medical clinic services
- All-stock transaction preserves cash resources
- Share issuance at $0.10 may lead to dilution for existing shareholders
- Non-binding LOI carries execution risk
- Loss of board member requires additional search and transition period
TORONTO, ON / / April 1, 2025 / Datametrex AI Limited (the "Company" or "Datametrex'') (TSXV:DM)(FSE:D4G)(OTC PINK:DTMXF) is pleased to announce the signing of a non-binding Letter of Intent ("LOI") to acquire Arbutus Health and Wellness Inc. ("Arbutus Health"), a multidisciplinary medical clinic in Vancouver Canada, on March 20, 2025.
Datametrex has agreed to acquire Arbutus Health for the Purchase Price of up to
Arbutus Health provides walk-in services, family medicine, skin laser treatments, and other specialty healthcare services in a single location.
The transaction is not a Non-Arm's Length Transaction, and no finder's fees will be paid. Completion of the Acquisition is subject to customary closing conditions, definitive agreements, and regulatory approvals. The Company will provide an update through a subsequent press release once a definitive agreement has been reached.
Paul Haber, CEO of Datametrex, commented, "We are pleased to take this strategic step in expanding our healthcare business. This acquisition strengthens our presence in the sector and aligns with our long-term growth strategy, allowing us on scale our operations and enhance service offerings."
Additionally, Datametrex announces that Richard Yoon has resigned from the Board of Directors, effective March 28, 2025. The Company thanks Mr. Yoon for his contributions and leadership and wishes him the best in his future endeavors. The Board will begin the process of identifying a suitable replacement in due course and further updates will be announced in the future release.
About Arbutus Health
Arbutus Health is a multidisciplinary medical clinic designed to address wait times and fragmented care in Canada's health system. Walk-in services, family doctors, skin laser treatments, and other specialties are integrated under one roof to provide timely and comprehensive care without requiring multiple referrals. Staffed by licensed healthcare professionals, patient satisfaction will be enhanced through innovative, efficient, and high-quality healthcare solutions.
About Datametrex
Datametrex is an innovative leader in Technology Solutions, Artificial Intelligence, Healthcare, and Mobile Gaming. The Company excels in delivering tools and solutions that enhance operational efficiencies and business outcomes. With a commitment to innovation, Datametrex is dedicated to supporting enterprises by setting a new standard for business protocols through cutting-edge technology.
For more on Datametrex, please visit our .
For Additional Information
Paul Haber, C.P.A., C.A., C.Dir
CEO & Chairman
[email protected]
(416) 318-6501
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This news release contains "forward-looking statements," which involve risks, uncertainties, and factors that could cause actual results to differ materially from those anticipated. These statements are not historical facts and are generally identified by words such as "expects," "plans," "anticipates," "believes," "intends," "estimates," "projects," and similar expressions. Such statements include expectations related to healthcare business and other Company plans.
While Datametrex believes the forward-looking information is reasonable as of the date of this release, these statements involve assumptions, risks, and uncertainties that could cause actual outcomes to differ. Key factors include general economic conditions, legislative and regulatory developments, access to capital, industry competition, and the Company's ability to execute its strategies. The Company does not undertake to update these statements, except as required by law. Readers are advised not to place undue reliance on forward-looking information.
Factors that could cause actual results to differ materially are detailed under "Risk Factors" in Datametrex's management's discussion and analysis and available on the Company's profile at www.sedarplus.ca.
This release does not constitute an offer to sell or a solicitation to buy, nor shall it constitute an offer, solicitation, or sale in any jurisdiction where such would be unlawful prior to registration or qualification under applicable securities laws. We seek Safe Harbor.
SOURCE: DataMetrex AI Ltd.
View the original on ACCESS Newswire
FAQ
What is the purchase price for Datametrex's acquisition of Arbutus Health?
What services does Arbutus Health provide that DTMXF is acquiring?
When did Datametrex sign the LOI to acquire Arbutus Health?
What conditions need to be met for DTMXF to complete the Arbutus Health acquisition?
